Method: Description and illustration of the surgical technique and indications for the modified nasoseptal flap for chronic sphenoid sinusitis. We report 3 cases of recurrent sphenoid fungal sinusitis treated with revision endoscopic sinusotomy and a mini-nasoseptal flap.
Results:
The mini-nasoseptal flap was used successfully in all cases without evidence of restenosis in the follow-up period. There were no complications related to flap harvest or inset.
Conclusion: Inflammatory sphenoid lesions such as fungal balls may increase the risk of postoperative ostial stenosis especially in cases when postoperative surveillance or debridement is difficult or impossible. The mini-nasoseptal flap may expedite healing and decrease the risk of restenosis after sphenoid sinusotomy by avoiding cicatricial scarring.
Rhinology/Allergy Mometasone Furoate for adenoidal Hypertrophy in adolescents
Asli Sahin-Yilmaz, MD (presenter); Saban Celebi; H. Baki Yilmaz; Cagatay Oysu, MD Objective: 1) To find out whether the symptoms attributable to adenoid hypertrophy in adolescents may be treated with intranasal mometasone furoate (MF) application. 2) To learn if adenoid hypertrophy in adolescents may decrease in size with intranasal MF.
Method: A prospective, double-blind, randomized, crossover study was conducted in 28 subjects (12-18 years) with adenoidal hypertrophy. Subjects used intranasal MF or placebo for a duration of 6 weeks with a washout period of 3 weeks. Subjective symptoms and adenoid size were evaluated.
Results:
At the initiation of the study, there was no significant difference between the mean symptom scores for any of the sinonasal symptoms between the 2 treatment groups. Placebo users had no statistically significant reduction in their sinonasal symptoms (P > .05 for all) other than snoring (P = .011). MF users had a statistically significant reduction in all symptoms (P < .05 for all) other than coughing (P = .527). There was a significant difference between the 2 treatment groups in the mean posttreatment scores for total subjective symptom scoring and rhinorrhea (P = .031, P = .012 resp). There was no significant difference in baseline endoscopy scores between the 2 treatment groups (P = .317). There was a significant reduction in nasal endoscopy scores in the MF group compared to placebo group (P = .034).
Conclusion: MF may have some advantage over placebo for the symptoms attributable to adenoid hypertrophy in adolescents. Intranasal MF decreases the size of the adenoid hypertrophy in this group of patients.
Rhinology/Allergy
New technique for the Endoscopic treatment of CSF Fistulas Juan C. Chaparro Morante, MD (presenter); Monica Hidalgo Venegas; Alberto Trelles Polo Y. La Borda Objective: 1) Report our experience in surgical treatment for closure of CSF fistulas of different etiologies, with a new endoscopic technique without invasive surgery. 2) Improve the treatment of CSF leakage, thus avoiding craniotomy and its sequelae.
Method:
We present 5 cases of adult patients with CSF fistula treated by endoscopic surgery from July to December 2011 using cartilage and mucoperichondrium tragal graft, resorbable thread as a guide and sterile sponge, previus revivig edges. Overlay technique was used and nasal packing was for 5 days. Endoscopic controls were carried out.
Results: In all surgery cases closure of the fistula was observed at 6 weeks. There were no recurrences and no reoperationes were necessary. All patients improved their symptoms without reoccurring liquorrhea.
Conclusion: Endoscopic closure of CSF fistulas with the technique of cartilage graft has proved a very safe method for this type of defect in the skull base as well as being reliable, secure, and free of sequelae known as craniotomies.
Rhinology/Allergy
Nitric Oxide Synthase in the Nasal Mucosa Shigetoshi Yoda, MD (presenter); Hisaki Fukushima; Dai Shibata; Takeshi Akisada; Tamotsu Harada Objective: The amount of nitric oxide (NO) in the nasal cavity is significantly higher in allergic rhinitis patients than in healthy individuals. The purpose of this study was to identify NO synthase (NOS) isoforms (NOS-1, NOS-2, and NOS-3) and examine their localization, gene expression, and protein expression in allergic rhinitis model mice.
Method: Male BALB/c mice were intraperitoneally administered Cryptomeria japonica 1 (Cryj1) and adjuvant (primary immunization) 3 times; thereafter, Cryj1 was administered daily into the nasal cavity (secondary immunization). The expression of NOS-1, NOS-2, and NOS-3 in the nasal mucosa was investigated using real-time polymerase chain reaction, and Western blot analysis.
Results: The expression of NOS-1 mRNA was significantly decreased, and NOS-2 and NOS-3 mRNA levels were significantly increased in the allergy group compared to the control group. Protein expression of NOS-1 was significantly decreased and that of NOS-2 was significantly increased in
